Matchpoint Therapeutics Company
Matchpoint Therapeutics is a biotechnology company that integrates chemoproteomics, ML, and covalent chemistry to treat serious illnesses.
Connections from
Headquarters:
Cambridge, Massachusetts, United States
Total Funding:
100000000.0
Founded Date:
2021-01-01
Last Funding Type:
Series A
Investors Number:
6.0
Last Funding Date:
2022-10-14
Funding Status:
Early Stage Venture
Industry:
Early Drug Development